Novartis AG (NVS) Stock Analysis

Not Halal Healthcare
Price $150.80
Market Cap $299.78B
Change +33.58%

Is NVS a good investment?

Novartis AG (NVS) has a Plutrex AI rating of pending review as of May 26, 2026, indicating a pending review consensus. The stock is not classified as halal-compliant.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is NVS a halal stock?

No, Novartis AG (NVS) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for NVS?

Novartis AG (NVS) has a Plutrex AI rating of pending review with a pending review consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is NVS a good investment?

According to Plutrex AI, NVS has a pending review rating (pending review). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in NVS?

US stocks like NVS can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in NVS?

Plutrex AI identifies the main risks for NVS by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with Plutrex AI about NVS

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open NVS in Plutrex